Advertisement

Biologic Treatment of Ligament Injuries by the Sports Physician

  • Jonas Pogorzelski
  • Mitchell Kennedy
  • Robert F. LaPradeEmail author
Chapter

Abstract

While extra-articular ligaments such as the medial collateral ligament (MCL) benefit from the absence of adverse effects from synovial fluid and therefore rarely encounter issues of healing absent of intervention, intra-articular ligament injuries, for instance an anterior cruciate ligament (ACL) tear, requires biological intervention to assist with native healing due to a lack of intrinsic healing potential. To enhance healing capacities, different types of biologics such as growth factors and stem cells can be applied. The intended goals for the use of biologics in ligament injuries are primarily geared toward accelerating healing while minimizing the risk of a reinjury. While the results of preclinical and basic science studies are promising, to date there is insufficient evidence to suggest that the use of biologics provides any significant clinical benefit.

Keywords

Ligament injury Biologics Mesenchymal stem cells Platelet-rich plasma Growth factors 

References

  1. 1.
    Centeno CJ, Pitts J, Al-Sayegh H, et al. Anterior cruciate ligament tears treated with percutaneous injection of autologous bone marrow nucleated cells: a case series. J Pain Res. 2015;8:437–47.PubMedPubMedCentralGoogle Scholar
  2. 2.
    Chahla J, Cinque ME, Piuzzi NS, et al. A call for standardization in platelet-rich plasma preparation protocols and composition reporting: a systematic review of the clinical orthopaedic literature. J Bone Joint Surg Am. 2017;99:1769–79.CrossRefGoogle Scholar
  3. 3.
    Chahla J, Mannava S, Cinque ME, et al. Bone marrow aspirate concentrate harvesting and processing technique. Arthrosc Tech. 2017;6:e441–5.CrossRefGoogle Scholar
  4. 4.
    Cheng M, Johnson VM, Murray MM. Effects of age and platelet-rich plasma on ACL cell viability and collagen gene expression. J Orthop Res. 2012;30:79–85.CrossRefGoogle Scholar
  5. 5.
    Cheng MT, Liu CL, Chen TH, et al. Comparison of potentials between stem cells isolated from human anterior cruciate ligament and bone marrow for ligament tissue engineering. Tissue Eng Part A. 2010;16:2237–53.CrossRefGoogle Scholar
  6. 6.
    Cinque ME, Dornan GJ, Chahla J, et al. High rates of osteoarthritis develop after anterior cruciate ligament surgery: an analysis of 4108 patients. Am J Sports Med. 2017;46(8):2011–9.  https://doi.org/10.1177/0363546517730072.CrossRefPubMedGoogle Scholar
  7. 7.
    Dallo I, Chahla J, Mitchell JJ, et al. Biologic approaches for the treatment of partial tears of the anterior cruciate ligament: a current concepts review. Orthop J Sports Med. 2017;5:2325967116681724.CrossRefGoogle Scholar
  8. 8.
    Figueroa D, Figueroa F, Calvo R, et al. Platelet-rich plasma use in anterior cruciate ligament surgery: systematic review of the literature. Arthroscopy. 2015;31:981–8.CrossRefGoogle Scholar
  9. 9.
    Frobell RB, Lohmander LS, Roos HP. Acute rotational trauma to the knee: poor agreement between clinical assessment and magnetic resonance imaging findings. Scand J Med Sci Sports. 2007;17:109–14.PubMedGoogle Scholar
  10. 10.
    Kanaya A, Deie M, Adachi N, et al. Intra-articular injection of mesenchymal stromal cells in partially torn anterior cruciate ligaments in a rat model. Arthroscopy. 2007;23:610–7.CrossRefGoogle Scholar
  11. 11.
    Laprade RF, Dragoo JL, Koh JL, et al. AAOS research symposium updates and consensus: biologic treatment of orthopaedic injuries. J Am Acad Orthop Surg. 2016;24:e62–78.CrossRefGoogle Scholar
  12. 12.
    Laprade RF, Geeslin AG, Murray IR, et al. Biologic treatments for sports injuries II think tank-current concepts, future research, and barriers to advancement, part 1: biologics overview, ligament injury, tendinopathy. Am J Sports Med. 2016;44:3270–83.CrossRefGoogle Scholar
  13. 13.
    Leslie M. Cell biology. Beyond clotting: the powers of platelets. Science. 2010;328:562–4.CrossRefGoogle Scholar
  14. 14.
    Li H, Hicks JJ, Wang L, et al. Customized platelet-rich plasma with transforming growth factor beta1 neutralization antibody to reduce fibrosis in skeletal muscle. Biomaterials. 2016;87:147–56.CrossRefGoogle Scholar
  15. 15.
    Moatshe G, Morris ER, Cinque ME, et al. Biological treatment of the knee with platelet-rich plasma or bone marrow aspirate concentrates. Acta Orthop. 2017;88:670–4.CrossRefGoogle Scholar
  16. 16.
    Murray IR, Geeslin AG, Goudie EB, et al. Minimum information for studies evaluating biologics in orthopaedics (MIBO): platelet-rich plasma and mesenchymal stem cells. J Bone Joint Surg Am. 2017;99:809–19.CrossRefGoogle Scholar
  17. 17.
    Murray MM, Fleming BC. Biology of anterior cruciate ligament injury and repair: kappa delta ann doner Vaughn award paper 2013. J Orthop Res. 2013;31:1501–6.CrossRefGoogle Scholar
  18. 18.
    Murray MM, Palmer M, Abreu E, et al. Platelet-rich plasma alone is not sufficient to enhance suture repair of the ACL in skeletally immature animals: an in vivo study. J Orthop Res. 2009;27:639–45.CrossRefGoogle Scholar
  19. 19.
    Oe K, Kushida T, Okamoto N, et al. New strategies for anterior cruciate ligament partial rupture using bone marrow transplantation in rats. Stem Cells Dev. 2011;20:671–9.CrossRefGoogle Scholar
  20. 20.
    Pogorzelski J, Godin JA, Fritz EM, et al. The use of biological approaches in the treatment of shoulder pathology: a critical analysis review. JBJS Rev. 2017;e5:5.CrossRefGoogle Scholar
  21. 21.
    Richmond JC, Weitzel PP. Bioresorbable scaffolds for anterior cruciate ligament reconstruction: do we need an off-the-shelf ACL substitute? Sports Med Arthrosc. 2010;18:40–2.CrossRefGoogle Scholar
  22. 22.
    Silva A, Sampaio R, Fernandes R, et al. Is there a role for adult non-cultivated bone marrow stem cells in ACL reconstruction? Knee Surg Sports Traumatol Arthrosc. 2014;22:66–71.CrossRefGoogle Scholar
  23. 23.
    Terada S, Ota S, Kobayashi M, et al. Use of an antifibrotic agent improves the effect of platelet-rich plasma on muscle healing after injury. J Bone Joint Surg Am. 2013;95:980–8.CrossRefGoogle Scholar

Copyright information

© ISAKOS 2019

Authors and Affiliations

  • Jonas Pogorzelski
    • 1
  • Mitchell Kennedy
    • 2
  • Robert F. LaPrade
    • 3
    Email author
  1. 1.Department of Orthopaedic Sports MedicineHospital Rechts der Isar, Technical University of MunichMunichGermany
  2. 2.Steadman Philippon Research InstituteVailUSA
  3. 3.Twin Cities OrthopaedicsMinneapolisUSA

Personalised recommendations